Overview
Cardiac resynchronization therapy.
Implantable defibrillator, including inappropriate shocks.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Hypertrophic cardiomyopathy.
Long QT syndrome
Sudden cardiac arrest and resuscitation.
Ventricular tachycardia
Current Appointments & Affiliations
Professor of Medicine
·
2010 - Present
Medicine, Cardiology,
Medicine
Recent Publications
Use of a Stylet Driven Lead With a Flexible Neck for Left Bundle Branch Area Pacing: A Single Center Experience.
Journal Article J Cardiovasc Electrophysiol · April 2025 BACKGROUND: The majority of data on left bundle branch area pacing (LBBAP) are on a lumenless lead. Data on the safety and effectiveness of stylet driven leads are comparatively lacking. METHODS: We retrospectively analyzed 265 patients who underwent attem ... Full text Link to item CiteReassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure.
Journal Article Heart Rhythm · April 2025 The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic ICD for the primary preve ... Full text Link to item CiteIs it the atrial arrhythmia or the atrial myopathy? Yes! (It's both).
Journal Article Trends Cardiovasc Med · March 4, 2025 Full text Link to item CiteRecent Grants
PKP2 Dose Escalation Trial of RP-A601
Clinical TrialPrincipal Investigator · Awarded by Rocket Pharmaceuticals, Ltd · 2024 - 2029The Natural History of Arrhythmogenic Cardiomyopathy with Pathogenic PKP2 Variants (PKP2-ACM): An observational cohort study
Clinical TrialPrincipal Investigator · Awarded by Rocket Pharmaceuticals, Ltd · 2025 - 2029AdaptResponse
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2015 - 2022View All Grants
Education, Training & Certifications
Thomas Jefferson University ·
1984
M.D.